Ads
related to: acadia pharmaceuticalsgrandriverasepticmfg.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Total equity. US$699.14 million (2019) Number of employees. 570 (June 30, 2020) Website. acadia .com. Footnotes / references. [1] Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California.
(Reuters) -Acadia Pharmaceuticals said on Monday it does not plan to conduct further clinical trials of its antipsychotic drug, pimavanserin, after it failed to improve negative symptoms of ...
Pimavanserin. Pimavanserin, sold under the brand name Nuplazid, is an atypical antipsychotic which is approved for the treatment of Parkinson's disease psychosis and is also being studied for the treatment of Alzheimer's disease psychosis, schizophrenia, agitation, and major depressive disorder. [3] Unlike other antipsychotics, pimavanserin is ...
ACADIA Pharmaceuticals Inc. ( NASDAQ:ACAD ) is possibly approaching a major achievement in its business, so we would...
What: Shares of ACADIA Pharmaceuticals -- a. Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're ...
Acadia Pharmaceuticals (ACAD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. Is a Surprise Coming for Acadia ...
Ads
related to: acadia pharmaceuticalsgrandriverasepticmfg.com has been visited by 10K+ users in the past month